Vivotif® Typhoid Vaccine Live Oral Ty21a

ABOUT VIVOTIF® Vivotif® (Typhoid vaccine live oral attenuated Ty21a) is indicated for: immunization of adults and children against disease caused by Salmonella typhi (new nomenclature: Salmonella enterica subspecies enterica serovar Typhi). Please review important safety information (ISI) for Vivotif® on our website: https://bit.ly/4ekDwUT COMMUNITY GUIDELINES We have a presence on social media platforms that you can use to keep up to date with Vivotif® (Typhoid vaccine live oral attenuated Ty21a) news and activities. Our goal is to provide useful and interesting content about our company, and foster an open and respectful dialogue. These accounts are subject to our community guidelines, which can be reviewed here: https://bit.ly/46b2zGi In addition to the privacy policy and terms of use of the third-party social media platform, your use of our social properties are governed by our Terms and Conditions of Use: https://www.bavarian-nordic.com/about/terms-of-use.aspx and Privacy Policy: https://www.bavarian-nordic.com/privacy/privacy.aspx. Intended for US audiences only.